Yuxing Li, PhD
Professor of Microbiology and Immunology
University of Maryland School of Medicine
Novel Clostridium difficile Binary Toxin Neutralizing Antibody as Therapeutic Agent
C. difficile bacteria produce toxins that damage the intestinal mucosa, causing severe illness and even death. This project explores the use of new toxin-neutralizing antibodies that could blunt the impact of this infection.
For more information about this technology, please contact the UM Ventures, Baltimore team.
Bio
Dr. Yuxing Li obtained her PhD degree from Iowa State University majored in Genetics. After a postdoc training under the supervision of Dr. Susan Carpenter at Iowa State University on lentivirus pathogenesis and persistence, she joined Dr. Richard T. Wyatt’s laboratory in the Vaccine Research Center (VRC), NIAID/NIH as a research fellow. At VRC, Dr. Li interacted and worked closely with scientists working on HIV structural biology, virology, and immunology, including Peter Kwong, Mark Connors, Mario Roederer, and John Mascola. During the training at VRC, Dr. Li started to develop an integrated research program focused on HIV vaccine rational design based on HIV envelope glycoprotein structural and immunologic analysis. In 2010, Dr. Li joined the IAVI Neutralizing Antibody Center at The Scripps Research Institute as an Assistant Professor of Immunology, based in La Jolla, California. In 2014, Dr. Li relocated her laboratory to the Institute for Bioscience and Biotechnology Research (IBBR) in Rockville, Maryland and affiliated with Department of Microbiology and Immunology, University of Maryland School of Medicine.